Back to MORGAN STANLEY MORGAN STANLEY

TRDATRDA
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in ENTRADA THERAPEUTICS INC

MORGAN STANLEY holds 191,650 shares of TRDA (ENTRADA THERAPEUTICS INC), worth $1.4M as of 2026-Q2. The position was increased (+8.8% shares). TRDA represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$1.4M

Current Shares

191,650

Total Value Change

-$79,848

Total Shares Change

+98,384

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
191,650
+8.8%
$1.4M0.0%$7.36
28
2026-Q1
Decreased
176,126
-32.3%
$2.2M0.0%$11.85
0
2025-Q4
Decreased
260,251
-24.9%
$2.7M0.0%$10.09
0
2025-Q3
Increased
346,756
+112.6%
$2M0.0%$5.84
42
2025-Q2
Increased
163,097
+121.4%
$1.1M0.0%$6.91
41
2025-Q1
Decreased
73,661
-10.0%
$665,8950.0%$9.56
0
2024-Q4
Decreased
81,873
-12.2%
$1.4M0.0%$17.37
0
2024-Q3
Increased
93,266
+90.1%
$1.5M0.0%$16.45
40

Other major holders of TRDA: BAKER BROS. ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used